(Q35148421)

6 August 2017

1 reference

title

The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction (English)

1 reference

6 August 2017

Alvin H Schmaier

1

1 reference

6 August 2017

1 July 2003

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

6 August 2017

1 reference

6 August 2017

285

1 reference

6 August 2017

R1-13

1 reference

6 August 2017

1

1 reference

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

6 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Regulation of renin: new evidence from cultured cells and genetically modified mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

21 January 2018

Two ACEs and a heart.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Vascular inflammation and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensinogen and its cleaved derivatives inhibit angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Kininogens are antithrombotic proteins In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Activation of Inactive Plasma Renin by Plasma and Tissue Kallikreins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Participation of kinins in the captopril-induced inhibition of intimal hyperplasia caused by interruption of carotid blood flow in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Targeting kinin B(1) receptor for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

An enzyme in microsomal fraction of kidney that inactivates bradykinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

The choreography of cyclooxygenases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

ACE inhibitor potentiation of bradykinin-induced venoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

[Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Renin-activation by kallikrein: evidence for alkaline-activation of plasma renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Prorenin processing and restricted endoproteolysis by mouse tissue kallikrein family enzymes (mK1, mK9, mK13, and mK22)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Enhancement of bradykinin and resensitization of its B2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Cathepsin B is a prorenin processing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Human prolylcarboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloprotease inhibitor-related protein from rat brain astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Arterial baroreceptor reflex function in borderline hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin-(1-7): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Linking the kallikrein and renin systems via activation of inactive renin: new data and a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

In vivo bradykinin B2 receptor activation reduces renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

The plasma kallikrein-kinin system counterbalances the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Endothelial AT(2)-receptors: chicken or egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

New enzymatic route for the inactivation of angiotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Hyperglycemia modulates angiotensinogen gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

Second Kininase in Human Blood Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00535.2002

10.1152/AJPREGU.00535.2002

21 January 2018

Identifiers

DOI

1 reference

release_3qssizumijdgjjzannybish4k4

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3qssizumijdgjjzannybish4k4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12793984

1 reference

PubMed ID

12793984